A plasma tracer and a red blood cell tracer can be evaluated separately after each reaches the bloodstream. The measured concentration of each label indicates the distribution volume of its corresponding compartment. This distinction allows clinicians to assess whether an abnormal total blood volume reflects altered plasma, altered cellular volume, or changes affecting both components.
The method relates a known tracer amount to the concentration measured after mixing in the circulation. When the tracer distributes through a larger volume, its concentration is lower; when it occupies a smaller volume, its concentration is higher. This dilution relationship converts a blood sample measurement into an estimate of the relevant circulating compartment.
Hematocrit describes the proportion of blood occupied by red blood cells, but it does not by itself establish the absolute amount of circulating blood or plasma. Blood volume measurement adds compartment-specific quantitative information. Consequently, it can help distinguish changes in fluid balance from changes in cellular concentration when routine vital signs or hematocrit do not provide enough information.
The findings are interpreted by considering measured plasma and cellular volumes rather than relying on a single blood concentration. Reduced circulating volume supports assessment of hypovolemia, while an increased red blood cell compartment can support evaluation of polycythemia. Conversely, a reduced cellular compartment may contribute to assessment of anemia, particularly when concentration-based measures are difficult to interpret.
The procedure begins with introduction of a known quantity of a labeled tracer into the bloodstream. The tracer is allowed to mix within the circulation, after which a blood sample is obtained and its concentration is measured. The resulting dilution is used to estimate the distribution volume, with separate measurements possible for plasma and red blood cells.
Assessment requires the amount of tracer introduced, adequate circulation for the label to mix, and a blood sample for concentration measurement. When plasma and red blood cell compartments must be distinguished, separate tracers can be used. These measurements support calculation of compartment-specific distribution volumes rather than relying only on a general blood concentration.
Clinicians may use the measurement when they need quantitative information about circulatory status or fluid balance. It can support evaluation of suspected hypovolemia, polycythemia, anemia, and abnormal fluid shifts. The results may also assist treatment planning and the assessment of physiological changes when routine vital signs provide an incomplete picture.
By quantifying circulating plasma and cellular components, the results provide more specific information about the nature of a volume abnormality. That information can help clinicians evaluate fluid shifts, support diagnostic decisions, and assess physiological changes over time. In medicine, this makes the measurement relevant when management depends on distinguishing altered fluid volume from altered red blood cell volume.